CNDO Key Stats
- CORONADO BIOSCIENCES INC Files SEC form 8-K/A, Unregistered Sale of Equity Securities, Change in Directors or Princip Yahoo 02/26 16:45 ET
- Is A Short Squeeze Ahead for Coronado Biosciences (CNDO)? Yahoo 02/26 09:25 ET
- Is A Short Squeeze Ahead for Coronado Biosciences (CNDO)? - Tale of the Tape Zacks 02/26 04:24 ET
- Nasdaq stocks posting largest volume increases Yahoo 02/21 18:06 ET
- CORONADO BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financi Yahoo 02/18 16:32 ET
- Qiagen to Simplify Next-Generation Sequencing - Analyst Blog Zacks 02/13 12:00 ET
- Zacks Rank #1 Additions for Thursday Yahoo 02/13 05:55 ET
- Zacks Rank #1 Additions for Thursday - Tale of the Tape Zacks 02/13 03:30 ET
- Coronado Shares Continue to Soar on Patent Approval Yahoo 02/10 16:00 ET
- Coronado Shares Continue to Soar on Patent Approval - Analyst Blog Zacks 02/10 11:00 ET
CNDO Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Coronado Biosciences is down 68.08% over the last year vs S&P 500 Total Return up 24.37%, Actelion up 101.5%, and Emergent BioSolutions up 75.87%.
Balance Sheet View Statement
Pro Ratings for CNDO
Pro Strategies Featuring CNDO
Did Coronado Biosciences make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: United States
- Headquarters State/Province: Massachusetts
- Incorporation Country: United States
- Incorporation State/Province: Delaware
Coronado Biosciences Inc is a biopharmaceutical company focused on novel immunotherapy biologic agents for autoimmune diseases and cancer.